Table 5 Malaria treatment practices among children with caregiver-reported fever in conflict-affected setting of the South West and Littoral Regions of Cameroon
Variables | Category | Total | Study population | p-valuea | ||
|---|---|---|---|---|---|---|
IDPs No (%) | Returnee No (%) | Host No (%) | ||||
Medicine taken by the child at any time during the illness | Yes | 1154 | 290 (92.4) | 265 (95.7) | 599 (95.1) | 0.141 |
No | 67 | 24 (7.6) | 12 (4.3) | 31 (4.9) | ||
Antimalarial medicine taken by the child | ACT | 655 | 178 (55.1) | 124 (44.4) | 353 (54.4) | 0.011 |
Fansidar | 12 | 3 (9.9) | 6 (2.2) | 3 (0.5) | 0.053 | |
Chloroquine | 40 | 13 (4.0) | 10 (3.6) | 17 (2.6) | 0.461 | |
Amodiaquine | 165 | 40 (12.4) | 39 (14.0) | 86 (13.3) | 0.845 | |
Quinine injectable | 68 | 16 (5.0) | 16 (5.7) | 36 (5.5) | 0.900 | |
Artesunate injection | 40 | 9 (2.8) | 7 (2.5) | 24 (3.7) | 0.569 | |
Artesunate rectal | 38 | 23 (7.1) | 3 (1.1) | 12 (1.8) | < 0.001 | |
Other antimalarial | 57 | 14 (4.3) | 14 (5.0) | 29 (4.5) | 0.912 | |
Other medicine | Aspirin | 44 | 6 (1.9) | 9 (3.2) | 29 (4.5) | 0.110 |
Paracetamol | 535 | 141 (43.7) | 155 (55.6) | 239 (36.8) | < 0.001 | |
Ibuprofen | 35 | 1 (0.3) | 12 (4.3) | 22 (3.4) | 0.005 | |
Number of days spent after the fever before the child first took an ACT | Same day | 248 | 36 (18.4) | 44 (26.8) | 168 (36.9) | < 0.001 |
Next day | 286 | 84 (42.9) | 69 (42.1) | 133 (29.2) | ||
Two days after fever | 166 | 40 (20.4) | 27 (16.5) | 99 (21.8) | ||
More than two days after fever | 115 | 36 (18.4) | 24 (14.6) | 55 (12.1) | ||
Malaria treatment practice category | Inappropriate | 445 | 115 (58.4) | 96 (64.4) | 234 (56.1) | 0.210 |
Appropriate | 318 | 82 (41.6) | 53 (35.6) | 183 (43.9) | ||